Search for Clinical Trial Results
Laryngopharyngeal Reflux - 20 Studies Found
| Status | Study |
| Completed |
Study Name: Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Condition:
Interventions: Drug: dexlansoprazole dexlansoprazole 60 mg once daily for 3 months |
| Completed |
Study Name: Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy Condition:
Date: 2013-06-14 Interventions:
|
| Completed |
Study Name: Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis Condition:
Interventions: |
| Enrolling by invitation |
Study Name: Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin Condition: Laryngopharyngeal Reflux Date: 2015-09-16 Interventions: Device: UESAD Device designed to provide modest cricoid pressure to reduce reflux |
| Enrolling by invitation |
Study Name: Predictive Value of Subjective and Objective Measurement Tools for Extraesophageal Reflux Condition: Laryngopharyngeal Reflux Date: 2013-04-02 |
| Completed |
Study Name: Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device Condition: Laryngopharyngeal Reflux Date: 2013-05-16 Interventions: Device: Reza Band UES Assist Device Device is worn by patient to reduce or eliminate laryngopharyngeal r |
| Terminated |
Study Name: Anti-reflux Control to Decrease Post Tonsillectomy Pain Condition:
Date: 2013-01-25 Interventions: Drug: Omeprazole The principal investigator will be contacted and will work with the research pharmacist |
| Completed |
Study Name: Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Condition:
Date: 2006-09-05 Interventions:
|
| Completed |
Study Name: Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? Condition:
Date: 2007-03-05 Interventions:
|
| NOT_YET_RECRUITING |
Study Name: Lexiva for the Treatment of LPR Condition: Laryngopharyngeal Reflux Date: 2025-11-04 Interventions: A repurposing approach, prospective, placebo-controlled clinical trial of Lexiva (used at the FDA approved, manufacturers recommended dose for HIV (1, |